These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6464049)

  • 1. [Radiation protection in the operation of accelerator and plasma equipment].
    Ewen K
    Strahlentherapie; 1984 Jul; 160(7):445-50. PubMed ID: 6464049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Measurement and calculation of the air activation caused by 15 MeV continuous radiation emitted by a linear accelerator (author's transl)].
    Gremmel H; Ihnen E; Jensen JM
    Strahlentherapie; 1981 Mar; 157(3):187-90. PubMed ID: 6782714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutron dose per fluence and weighting factors for use at high energy accelerators.
    Cossairt JD; Vaziri K
    Health Phys; 2009 Jun; 96(6):617-28. PubMed ID: 19430214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton and heavy ion acceleration facilities for space radiation research.
    Miller J
    Gravit Space Biol Bull; 2003 Jun; 16(2):19-28. PubMed ID: 12959128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective energy determination in leakage radiation measurements.
    Lane RG
    Health Phys; 1977 Dec; 33(6):626-8. PubMed ID: 604309
    [No Abstract]   [Full Text] [Related]  

  • 6. A prediction of accelerator-produced activation products.
    Culp T
    Health Phys; 2007 Feb; 92(2 Suppl):S57-65. PubMed ID: 17228190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation impact caused by activation of air from the future GSI accelerator facility fair.
    Gutermuth F; Wildermuth H; Radon T; Fehrenbacher G
    Radiat Prot Dosimetry; 2005; 115(1-4):437-40. PubMed ID: 16381762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement and analysis of induced activities in concrete irradiated using high-energy neutrons at KENS Neutron Spallation Source Facility.
    Oishi K; Nakao N; Kosako K; Yamakawa H; Nakashima H; Kawai M; Yashima H; Sanami T; Numajiri M; Shibata T; Hirayama H; Nakamura T
    Radiat Prot Dosimetry; 2005; 115(1-4):623-9. PubMed ID: 16381795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The relationships between the specialist in radiology, the competent physician, the licensed physician and the qualified expert].
    Coppola V
    Radiol Med; 1998 Jun; 95(6):635-8. PubMed ID: 9717548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Technical aspects of protontherapy: Setup, equipment and radioprotection].
    Ferrand R
    Cancer Radiother; 2016 Oct; 20(6-7):519-22. PubMed ID: 27614510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radiation protection regulations in various countries (author's transl)].
    Hamada T
    Radioisotopes; 1980 Jul; 29(7):355-62. PubMed ID: 7208989
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the photoneutron field produced in a medical linear accelerator.
    Kim HS; Park YH; Koo BC; Kwon JW; Lee JS; Choi HS
    Radiat Prot Dosimetry; 2007; 123(3):323-8. PubMed ID: 17077093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Alternative Approach to Estimating Instrument Decision Thresholds for Clearance of Personal Property From Accelerator Facilities.
    Schaefer CW
    Health Phys; 2019 Jul; 117(1):99-105. PubMed ID: 30908274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Intensity Proton Accelerator Project in Japan (J-PARC).
    Tanaka S
    Radiat Prot Dosimetry; 2005; 115(1-4):33-43. PubMed ID: 16381679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental determination of peripheral doses for different IMRT techniques delivered by a Siemens linear accelerator.
    Wiezorek T; Voigt A; Metzger N; Georg D; Schwedas M; Salz H; Wendt TG
    Strahlenther Onkol; 2008 Feb; 184(2):73-9. PubMed ID: 18259698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ISABELLE shielding criteria and design.
    Gollon PJ; Casey WR
    Health Phys; 1984 Jan; 46(1):123-32. PubMed ID: 6319330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multileaf shielding design against neutrons produced by medical linear accelerators.
    Rebello WF; Silva AX; Facure A
    Radiat Prot Dosimetry; 2008; 128(2):227-33. PubMed ID: 17569690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TRADE experiment: shielding calculations for the building hosting the subcritical system.
    Burn KW; Carta M; Casalini L; Kadi Y; Monti S; Nava E; Palomba M; Petrovich C; Picardi L; Rubbia C; Troiani F
    Radiat Prot Dosimetry; 2005; 115(1-4):187-94. PubMed ID: 16381710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of the fluence response of the GSI neutron ball dosemeter in the energy range from thermal to 19 MeV.
    Fehrenbacher G; Kozlova E; Gutermuth F; Radon T; Schütz R; Nolte R; Böttger R
    Radiat Prot Dosimetry; 2007; 126(1-4):546-8. PubMed ID: 17561518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protecting people against radiation exposure in the event of a radiological attack. A report of The International Commission on Radiological Protection.
    Valentin J;
    Ann ICRP; 2005; 35(1):1-110, iii-iv. PubMed ID: 16164984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.